FM
NERV icon

Frazier Management’s Minerva Neurosciences NERV Stock Holding History

Frazier Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,693
Closed -$144K – 37
2020
Q4 		$144K Sell
7,693
-61,057
-89% -$1.54M 0.01% 35
2020
Q3 		$1.75M Buy
+68,750
New +$1.86M 0.16% 28

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Frazier Management's NERV Position: Q1 2021 in Review

Frazier Management sold out of Minerva Neurosciences (NERV) in Q1 2021, closing a stake of 7,693 shares — an estimated $144K sold.

Frazier Management first reported a position in NERV in Q3 2020 and held it in 2 quarters. The position peaked at $1.75M in Q3 2020. 72 funds tracked by Wall St. Rank hold NERV as of Q1 2021.

  • Frazier Management reported no remaining Minerva Neurosciences position as of Q1 2021 after selling out during the quarter.
  • Frazier Management sold 7,693 Minerva Neurosciences shares in Q1 2021, an estimated $144K.
  • Frazier Management first reported a position in Minerva Neurosciences in Q3 2020 and held it in 2 quarters.
  • Frazier Management's Minerva Neurosciences position peaked at $1.75M in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2021.

Based on Frazier Management's 13F filing for Q1 2021, filed 12 May 2021.